rdf:type |
|
lifeskim:mentions |
umls-concept:C0006118,
umls-concept:C0024487,
umls-concept:C0027540,
umls-concept:C0034897,
umls-concept:C0205210,
umls-concept:C0205421,
umls-concept:C0228174,
umls-concept:C0260061,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C1609982
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-1-23
|
pubmed:abstractText |
Delayed cerebral necrosis (DN) is a significant risk for brain tumor patients treated with high-dose irradiation. Although differentiating DN from tumor progression is an important clinical question, the distinction cannot be made reliably by conventional imaging techniques. We undertook a pilot study to assess the ability of proton magnetic resonance spectroscopy (1H MRS) to differentiate prospectively between DN or recurrent/residual tumor in a series of children treated for primary brain tumors with high-dose irradiation.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0360-3016
|
pubmed:author |
pubmed-author:ChenGG,
pubmed-author:FOXJ PJP,
pubmed-author:FoxI SIS,
pubmed-author:HeidemanR LRL,
pubmed-author:HsuD WDW,
pubmed-author:JenkinsJ JJJ3rd,
pubmed-author:KingsleyP BPB,
pubmed-author:LangstonJ WJW,
pubmed-author:OchsJ JJJ,
pubmed-author:ReddickW EWE,
pubmed-author:SanfordR ARA,
pubmed-author:TaylorJ SJS
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1251-61
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8985051-Adolescent,
pubmed-meshheading:8985051-Brain,
pubmed-meshheading:8985051-Brain Neoplasms,
pubmed-meshheading:8985051-Child,
pubmed-meshheading:8985051-Child, Preschool,
pubmed-meshheading:8985051-Female,
pubmed-meshheading:8985051-Humans,
pubmed-meshheading:8985051-Magnetic Resonance Imaging,
pubmed-meshheading:8985051-Magnetic Resonance Spectroscopy,
pubmed-meshheading:8985051-Male,
pubmed-meshheading:8985051-Necrosis,
pubmed-meshheading:8985051-Neoplasm, Residual,
pubmed-meshheading:8985051-Neoplasm Recurrence, Local,
pubmed-meshheading:8985051-Radiotherapy,
pubmed-meshheading:8985051-Sensitivity and Specificity
|
pubmed:year |
1996
|
pubmed:articleTitle |
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.
|
pubmed:affiliation |
Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|